AMC Stock Forecast, How High Could It Go in 2025 and Beyond?
AMC Entertainment (NYSE:AMC) has been rising lately after years of…
Buy
58
AHCO Quote, Financials, Valuation and Earnings
Last price:
$8.61
Seasonality move
:
4.62%
Day range:
$8.44 - $8.73
52-week range:
$7.11 - $11.90
Dividend yield:
0%
P/E ratio:
14.93x
P/S ratio:
0.36x
P/B ratio:
0.73x
Volume:
1.1M
Avg. volume:
1.1M
1-year change:
-24.56%
Market cap:
$1.1B
Revenue:
$3.3B
EPS (TTM):
$0.57
Analysts' Opinion
-
Consensus RatingAdaptHealth has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $12.88, AdaptHealth has an estimated upside of 51.29% from its current price of $8.51.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $9.50 representing 100% downside risk from its current price of $8.51.
Fair Value
-
According to the consensus of 7 analysts, AdaptHealth has 51.29% upside to fair value with a price target of $12.88 per share.
AHCO vs. S&P 500
-
Over the past 5 trading days, AdaptHealth has underperformed the S&P 500 by -2.51% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
AdaptHealth does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
AdaptHealth revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter AdaptHealth reported revenues of $580.5M.
Earnings Growth
-
AdaptHealth has grown year-over-year earnings for 1 quarter straight. In the most recent quarter AdaptHealth reported earnings per share of -$0.05.
Enterprise value:
3.1B
EV / Invested capital:
0.87x
Price / LTM sales:
0.36x
EV / EBIT:
12.34x
EV / Revenue:
0.94x
PEG ratio (5yr expected):
--
EV / Free cash flow:
11.14x
Price / Operating cash flow:
4.21x
Enterprise value / EBITDA:
4.98x
Gross Profit (TTM):
$685.7M
Return On Assets:
1.9%
Net Income Margin (TTM):
2.63%
Return On Equity:
5.59%
Return On Invested Capital:
2.39%
Operating Margin:
3.99%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $3B | $3.2B | $3.2B | $594.1M | $580.5M | |
| Gross Profit | $553.1M | $682.8M | $685.7M | -$40.9M | -$77M | |
| Operating Income | $165M | $245.8M | $229.8M | $57.1M | $23.2M | |
| EBITDA | $549.6M | -$220.6M | $614.7M | $130.8M | $117.5M | |
| Diluted EPS | $0.12 | -$5.27 | $0.57 | -$0.02 | -$0.05 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $503.5M | $615M | $646.7M | $656M | $745.2M | |
| Total Assets | $4.5B | $5.2B | $5.3B | $4.5B | $4.4B | |
| Current Liabilities | $513.1M | $443.6M | $524.5M | $492.7M | $576.7M | |
| Total Liabilities | $2.7B | $3.1B | $3.1B | $3B | $2.9B | |
| Total Equity | $1.8B | $2.1B | $2.2B | $1.5B | $1.6B | |
| Total Debt | $1.8B | $2.2B | $2.2B | $2.2B | $2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $447.7M | $389.5M | $588.3M | $49M | $95.5M | |
| Cash From Investing | -$420.6M | -$355.6M | -$318M | -$87.9M | -$95.6M | |
| Cash From Financing | -$45.1M | -$55.7M | -$296.3M | $41.3M | -$56M | |
| Free Cash Flow | $44.3M | $53.2M | $274.6M | -$38.9M | -$58K | |
AHCO
Sector
Market Cap
$1.1B
$32.6M
Price % of 52-Week High
71.51%
47.07%
Dividend Yield
0%
0%
Shareholder Yield
2.9%
-0.74%
1-Year Price Total Return
-24.56%
-37.62%
Beta (5-Year)
1.636
0.632
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$8.73
200-day SMA
Sell
Level
$9.85
Bollinger Bands (100)
Sell
Level
8.42 - 10.32
Chaikin Money Flow
Sell
Level
-32.7M
20-day SMA
Sell
Level
$8.88
Relative Strength Index (RSI14)
Sell
Level
41.35
ADX Line
Sell
Level
13.32
Williams %R
Buy
Level
-91.25
50-day SMA
Sell
Level
$8.67
MACD (12, 26)
Sell
Level
-0.07
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
14.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.0594)
Sell
CA Score
(Annual)
Level (-0.6667)
Buy
Beneish M-Score
(Annual)
Level (-2.9461)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-3.8527)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
Stock Forecast FAQ
In the current month, AHCO has received 5 Buy ratings 2 Hold ratings, and 0 Sell ratings. The AHCO average analyst price target in the past 3 months is $12.88.
-
Where Will AdaptHealth Stock Be In 1 Year?
According to analysts, the consensus estimate is that AdaptHealth share price will rise to $12.88 per share over the next 12 months.
-
What Do Analysts Say About AdaptHealth?
Analysts are divided on their view about AdaptHealth share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that AdaptHealth is a Sell and believe this share price will drop from its current level to $9.50.
-
What Is AdaptHealth's Price Target?
The price target for AdaptHealth over the next 1-year time period is forecast to be $12.88 according to 7 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is AHCO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for AdaptHealth is a Buy. 5 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of AHCO?
You can purchase shares of AdaptHealth via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase AdaptHealth shares.
-
What Is The AdaptHealth Share Price Today?
AdaptHealth was last trading at $8.61 per share. This represents the most recent stock quote for AdaptHealth. Yesterday, AdaptHealth closed at $8.51 per share.
-
How To Buy AdaptHealth Stock Online?
In order to purchase AdaptHealth stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Reddit Stock Be In 5 Years?
On a wet March morning last year, the famously orange…
Will Palantir Crash?
AI and data analytics software major Palantir (NASDAQ:PLTR) has been…
Stock Ideas
Buy
65
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Alerts
Sell
47
RGC alert for Jun 18
Regencell Bioscience Holdings [RGC] is down 18.36% over the past day.
Sell
20
ENPH alert for Jun 18
Enphase Energy [ENPH] is up 4.38% over the past day.
Sell
26
FSLR alert for Jun 18
First Solar [FSLR] is down 0.1% over the past day.
